WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis

Identifier

012054

Type of Spiritual Experience

Background

A description of the experience

Dermatoendocrinol. 2013 Jan 1;5(1):222-34. doi: 10.4161/derm.24808.  A pilot study assessing the effect of prolonged administration of high daily doses of vitamin D on the clinical course of vitiligo and psoriasis. Finamor DC1, Sinigaglia-Coimbra R1, Neves LC2, Gutierrez M3, Silva JJ1, Torres LD1, Surano F1, Neto DJ4, Novo NF5, Juliano Y5, Lopes AC6, Coimbra CG1.  Laboratório de Fisiopatologia Clínica e Experimental; Universidade Federal de São Paulo; São Paulo, Brazil; Instituto de Ciências da Saúde; Universidade Paulista; São Paulo, Brazil; Farmácia Sensitiva; São Paulo, Brazil; Hospital Heliópolis; São Paulo, Brazil; Disciplina de Cirurgia Plástica; Universidade Federal de São Paulo; São Paulo, Brazil;  Disciplina de Clínica Médica; Universidade Federal de São Paulo; São Paulo, Brazil.

Autoimmunity has been associated with vitamin D deficiency and resistance, with gene polymorphisms related to vitamin D metabolism frequently described in affected patients.

High doses of vitamin D3 may conceivably compensate for inherited resistance to its biological effects.

This study aimed to assess the efficacy and safety of prolonged high-dose vitamin D3 treatment of patients with psoriasis and vitiligo.

Nine patients with psoriasis and 16 patients with vitiligo received vitamin D3 35,000 IU once daily for six months in association with a low-calcium diet (avoiding dairy products and calcium-enriched foods like oat, rice or soya "milk") and hydration (minimum 2.5 L daily).

All psoriasis patients were scored according to "Psoriasis Area and Severity Index" (PASI) at baseline and after treatment. Evaluation of clinical response of vitiligo patients required a quartile grading scale.

All patients presented low vitamin D status (serum 25(OH)D3 ≤ 30 ng/mL) at baseline.

After treatment 25(OH)D3 levels significantly increased (from 14.9 ± 7.4 to 106.3 ± 31.9 ng/mL and from 18.4 ± 8.9 to 132.5 ± 37.0 ng/mL) and PTH levels significantly decreased (from 57.8 ± 16.7 to 28.9 ± 8.2 pg/mL and from 55.3 ± 25.0 to 25.4 ± 10.7 pg/mL) in patients with psoriasis and vitiligo respectively. PTH and 25(OH)D3 serum concentrations correlated inversely.

The PASI score significantly improved in all nine patients with psoriasis. Fourteen of 16 patients with vitiligo had 25-75% repigmentation. Serum urea, creatinine and calcium (total and ionized) did not change and urinary calcium excretion increased within the normal range.

High-dose vitamin D3 therapy may be effective and safe for vitiligo and psoriasis patients.

PMID: 24494059

The source of the experience

PubMed

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Psoriasis
Skin diseases

Suppressions

Dairy products
Vitamin D

Commonsteps

References